The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis-Reference-Cited by-同舟云学术

The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis

Published:2006-12 Issue:5 Volume:99 Page:1351-1362
ISSN:0022-3042
Container-title:Journal of Neurochemistry
language:en
Short-container-title:J Neurochem

Author:

Russo Cinzia Dello,Polak Paul E.,Mercado Pilar R.,Spagnolo Alessandra,Sharp Anthony,Murphy Patricia,Kamal Adeela,Burrows Francis J.,Fritz Lawrence C.,Feinstein Douglas L.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1471-4159.2006.04221.x/fullpdf

Reference54 articles.

1. Nitric oxide neurotoxicity in neurodegenerative diseases

2. Activation of NF-κB and c-jun Transcription Factors in Multiple Sclerosis Lesions

3. Requirement of Hsp90 activity for IκB kinase (IKK) biosynthesis and for constitutive and inducible IKK and NF-κB activation

4. Heat shock protein 90 mediates macrophage activation by Taxol and bacterial lipopolysaccharide

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Heat shock protein 90 inhibition attenuates inflammation in models of atopic dermatitis: a novel mechanism of action;Frontiers in Immunology;2024-01-11

2. 17-DMAG ameliorates neuroinflammation and BBB disruption via SOX5 mediated PI3K/Akt pathway after intracerebral hemorrhage in rats;International Immunopharmacology;2023-10

3. TRPA1 activation and Hsp90 inhibition synergistically downregulate macrophage activation and inflammatory responses in vitro;BMC Immunology;2023-06-30

4. Integrating 3D genomic and epigenomic data to enhance target gene discovery and drug repurposing in transcriptome-wide association studies;Nature Communications;2022-06-07

5. HSP90 inhibitor RGRN‐305 for oral treatment of plaque type psoriasis: efficacy, safety and biomarker results in an open‐label proof‐of‐concept study;British Journal of Dermatology;2021-11-08